KVISTGAARD, Denmark, May 27 /PRNewswire/ -- Following the presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine candidate for the treatment of advanced prostate cancer, Bavarian Nordic will be hosting a QA session at the ASCO Annual Meeting.
Time: Sunday, May 31st 2009 from 09 AM EDT to 10 AM EDT.
Location: Rosen Centre Hotel, 9840 International Drive, Orlando, Florida 32819
At the QA session, Bavarian Nordic's PROSTVAC(TM) team and President CEO, Anders Hedegaard will attend.